line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,TIRUMALCHM.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,TIRUMALCHM.NS
Normalized EBITDA,2025-03-31 00:00:00,694000000.0,TIRUMALCHM.NS
Total Unusual Items,2025-03-31 00:00:00,,TIRUMALCHM.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,TIRUMALCHM.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Reconciled Depreciation,2025-03-31 00:00:00,611000000.0,TIRUMALCHM.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,15867100000.0,TIRUMALCHM.NS
EBITDA,2025-03-31 00:00:00,694000000.0,TIRUMALCHM.NS
EBIT,2025-03-31 00:00:00,83000000.0,TIRUMALCHM.NS
Net Interest Income,2025-03-31 00:00:00,-491500000.0,TIRUMALCHM.NS
Interest Expense,2025-03-31 00:00:00,491500000.0,TIRUMALCHM.NS
Interest Income,2025-03-31 00:00:00,,TIRUMALCHM.NS
Normalized Income,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Total Expenses,2025-03-31 00:00:00,20618100000.0,TIRUMALCHM.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,TIRUMALCHM.NS
Diluted Average Shares,2025-03-31 00:00:00,102444444.0,TIRUMALCHM.NS
Basic Average Shares,2025-03-31 00:00:00,102444444.0,TIRUMALCHM.NS
Diluted EPS,2025-03-31 00:00:00,-4.5,TIRUMALCHM.NS
Basic EPS,2025-03-31 00:00:00,-4.5,TIRUMALCHM.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Net Income Common Stockholders,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,TIRUMALCHM.NS
Net Income,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Net Income Continuous Operations,2025-03-31 00:00:00,-461000000.0,TIRUMALCHM.NS
Tax Provision,2025-03-31 00:00:00,52500000.0,TIRUMALCHM.NS
Pretax Income,2025-03-31 00:00:00,-408500000.0,TIRUMALCHM.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,206000000.0,TIRUMALCHM.NS
Special Income Charges,2025-03-31 00:00:00,,TIRUMALCHM.NS
Other Special Charges,2025-03-31 00:00:00,,TIRUMALCHM.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-491500000.0,TIRUMALCHM.NS
Total Other Finance Cost,2025-03-31 00:00:00,,TIRUMALCHM.NS
Interest Expense Non Operating,2025-03-31 00:00:00,491500000.0,TIRUMALCHM.NS
Interest Income Non Operating,2025-03-31 00:00:00,,TIRUMALCHM.NS
Operating Income,2025-03-31 00:00:00,-123000000.0,TIRUMALCHM.NS
Operating Expense,2025-03-31 00:00:00,4751000000.0,TIRUMALCHM.NS
Other Operating Expenses,2025-03-31 00:00:00,3255300000.0,TIRUMALCHM.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,611000000.0,TIRUMALCHM.NS
Amortization,2025-03-31 00:00:00,,TIRUMALCHM.NS
Depreciation Income Statement,2025-03-31 00:00:00,611000000.0,TIRUMALCHM.NS
Research And Development,2025-03-31 00:00:00,,TIRUMALCHM.NS
Selling General And Administration,2025-03-31 00:00:00,,TIRUMALCHM.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,TIRUMALCHM.NS
General And Administrative Expense,2025-03-31 00:00:00,,TIRUMALCHM.NS
Rent And Landing Fees,2025-03-31 00:00:00,,TIRUMALCHM.NS
Gross Profit,2025-03-31 00:00:00,4628000000.0,TIRUMALCHM.NS
Cost Of Revenue,2025-03-31 00:00:00,15867100000.0,TIRUMALCHM.NS
Total Revenue,2025-03-31 00:00:00,20495100000.0,TIRUMALCHM.NS
Operating Revenue,2025-03-31 00:00:00,20495100000.0,TIRUMALCHM.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,TIRUMALCHM.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,TIRUMALCHM.NS
Normalized EBITDA,2024-03-31 00:00:00,703600000.0,TIRUMALCHM.NS
Total Unusual Items,2024-03-31 00:00:00,3700000.0,TIRUMALCHM.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,3700000.0,TIRUMALCHM.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Reconciled Depreciation,2024-03-31 00:00:00,632000000.0,TIRUMALCHM.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,16640200000.0,TIRUMALCHM.NS
EBITDA,2024-03-31 00:00:00,703600000.0,TIRUMALCHM.NS
EBIT,2024-03-31 00:00:00,71600000.0,TIRUMALCHM.NS
Net Interest Income,2024-03-31 00:00:00,-417100000.0,TIRUMALCHM.NS
Interest Expense,2024-03-31 00:00:00,417100000.0,TIRUMALCHM.NS
Interest Income,2024-03-31 00:00:00,105700000.0,TIRUMALCHM.NS
Normalized Income,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Total Expenses,2024-03-31 00:00:00,20953100000.0,TIRUMALCHM.NS
Rent Expense Supplemental,2024-03-31 00:00:00,37000000.0,TIRUMALCHM.NS
Diluted Average Shares,2024-03-31 00:00:00,102348285.0,TIRUMALCHM.NS
Basic Average Shares,2024-03-31 00:00:00,102348285.0,TIRUMALCHM.NS
Diluted EPS,2024-03-31 00:00:00,-3.79,TIRUMALCHM.NS
Basic EPS,2024-03-31 00:00:00,-3.79,TIRUMALCHM.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Net Income Common Stockholders,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,TIRUMALCHM.NS
Net Income,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Net Income Continuous Operations,2024-03-31 00:00:00,-387900000.0,TIRUMALCHM.NS
Tax Provision,2024-03-31 00:00:00,42400000.0,TIRUMALCHM.NS
Pretax Income,2024-03-31 00:00:00,-345500000.0,TIRUMALCHM.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,193400000.0,TIRUMALCHM.NS
Special Income Charges,2024-03-31 00:00:00,3700000.0,TIRUMALCHM.NS
Other Special Charges,2024-03-31 00:00:00,-3700000.0,TIRUMALCHM.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-417100000.0,TIRUMALCHM.NS
Total Other Finance Cost,2024-03-31 00:00:00,58200000.0,TIRUMALCHM.NS
Interest Expense Non Operating,2024-03-31 00:00:00,417100000.0,TIRUMALCHM.NS
Interest Income Non Operating,2024-03-31 00:00:00,105700000.0,TIRUMALCHM.NS
Operating Income,2024-03-31 00:00:00,-121800000.0,TIRUMALCHM.NS
Operating Expense,2024-03-31 00:00:00,4312900000.0,TIRUMALCHM.NS
Other Operating Expenses,2024-03-31 00:00:00,2882700000.0,TIRUMALCHM.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,632000000.0,TIRUMALCHM.NS
Amortization,2024-03-31 00:00:00,1000000.0,TIRUMALCHM.NS
Depreciation Income Statement,2024-03-31 00:00:00,632000000.0,TIRUMALCHM.NS
Research And Development,2024-03-31 00:00:00,24700000.0,TIRUMALCHM.NS
Selling General And Administration,2024-03-31 00:00:00,1205700000.0,TIRUMALCHM.NS
Selling And Marketing Expense,2024-03-31 00:00:00,1033800000.0,TIRUMALCHM.NS
General And Administrative Expense,2024-03-31 00:00:00,171900000.0,TIRUMALCHM.NS
Rent And Landing Fees,2024-03-31 00:00:00,37000000.0,TIRUMALCHM.NS
Gross Profit,2024-03-31 00:00:00,4191100000.0,TIRUMALCHM.NS
Cost Of Revenue,2024-03-31 00:00:00,16640200000.0,TIRUMALCHM.NS
Total Revenue,2024-03-31 00:00:00,20831300000.0,TIRUMALCHM.NS
Operating Revenue,2024-03-31 00:00:00,20831300000.0,TIRUMALCHM.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,3120180.0,TIRUMALCHM.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3059,TIRUMALCHM.NS
Normalized EBITDA,2023-03-31 00:00:00,2102700000.0,TIRUMALCHM.NS
Total Unusual Items,2023-03-31 00:00:00,10200000.0,TIRUMALCHM.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,10200000.0,TIRUMALCHM.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,898300000.0,TIRUMALCHM.NS
Reconciled Depreciation,2023-03-31 00:00:00,556800000.0,TIRUMALCHM.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,15589000000.0,TIRUMALCHM.NS
EBITDA,2023-03-31 00:00:00,2112900000.0,TIRUMALCHM.NS
EBIT,2023-03-31 00:00:00,1556100000.0,TIRUMALCHM.NS
Net Interest Income,2023-03-31 00:00:00,-147300000.0,TIRUMALCHM.NS
Interest Expense,2023-03-31 00:00:00,262000000.0,TIRUMALCHM.NS
Interest Income,2023-03-31 00:00:00,165200000.0,TIRUMALCHM.NS
Normalized Income,2023-03-31 00:00:00,891220180.0,TIRUMALCHM.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,898300000.0,TIRUMALCHM.NS
Total Expenses,2023-03-31 00:00:00,19895100000.0,TIRUMALCHM.NS
Rent Expense Supplemental,2023-03-31 00:00:00,36800000.0,TIRUMALCHM.NS
Diluted Average Shares,2023-03-31 00:00:00,102388120.0,TIRUMALCHM.NS
Basic Average Shares,2023-03-31 00:00:00,102388120.0,TIRUMALCHM.NS
Diluted EPS,2023-03-31 00:00:00,8.77,TIRUMALCHM.NS
Basic EPS,2023-03-31 00:00:00,8.77,TIRUMALCHM.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,898300000.0,TIRUMALCHM.NS
Net Income Common Stockholders,2023-03-31 00:00:00,898300000.0,TIRUMALCHM.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,TIRUMALCHM.NS
Net Income,2023-03-31 00:00:00,898300000.0,TIRUMALCHM.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,898300000.0,TIRUMALCHM.NS
Net Income Continuous Operations,2023-03-31 00:00:00,898300000.0,TIRUMALCHM.NS
Tax Provision,2023-03-31 00:00:00,395800000.0,TIRUMALCHM.NS
Pretax Income,2023-03-31 00:00:00,1294100000.0,TIRUMALCHM.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,10700000.0,TIRUMALCHM.NS
Special Income Charges,2023-03-31 00:00:00,10500000.0,TIRUMALCHM.NS
Other Special Charges,2023-03-31 00:00:00,-10500000.0,TIRUMALCHM.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-147300000.0,TIRUMALCHM.NS
Total Other Finance Cost,2023-03-31 00:00:00,50500000.0,TIRUMALCHM.NS
Interest Expense Non Operating,2023-03-31 00:00:00,262000000.0,TIRUMALCHM.NS
Interest Income Non Operating,2023-03-31 00:00:00,165200000.0,TIRUMALCHM.NS
Operating Income,2023-03-31 00:00:00,1308200000.0,TIRUMALCHM.NS
Operating Expense,2023-03-31 00:00:00,4306100000.0,TIRUMALCHM.NS
Other Operating Expenses,2023-03-31 00:00:00,1610200000.0,TIRUMALCHM.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,556800000.0,TIRUMALCHM.NS
Amortization,2023-03-31 00:00:00,700000.0,TIRUMALCHM.NS
Depreciation Income Statement,2023-03-31 00:00:00,556100000.0,TIRUMALCHM.NS
Research And Development,2023-03-31 00:00:00,25300000.0,TIRUMALCHM.NS
Selling General And Administration,2023-03-31 00:00:00,1377100000.0,TIRUMALCHM.NS
Selling And Marketing Expense,2023-03-31 00:00:00,1182500000.0,TIRUMALCHM.NS
General And Administrative Expense,2023-03-31 00:00:00,194600000.0,TIRUMALCHM.NS
Rent And Landing Fees,2023-03-31 00:00:00,36800000.0,TIRUMALCHM.NS
Gross Profit,2023-03-31 00:00:00,5614300000.0,TIRUMALCHM.NS
Cost Of Revenue,2023-03-31 00:00:00,15589000000.0,TIRUMALCHM.NS
Total Revenue,2023-03-31 00:00:00,21203300000.0,TIRUMALCHM.NS
Operating Revenue,2023-03-31 00:00:00,21203300000.0,TIRUMALCHM.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-50480.0,TIRUMALCHM.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.2524,TIRUMALCHM.NS
Normalized EBITDA,2022-03-31 00:00:00,4489300000.0,TIRUMALCHM.NS
Total Unusual Items,2022-03-31 00:00:00,-200000.0,TIRUMALCHM.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-200000.0,TIRUMALCHM.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,2812300000.0,TIRUMALCHM.NS
Reconciled Depreciation,2022-03-31 00:00:00,566300000.0,TIRUMALCHM.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,12146400000.0,TIRUMALCHM.NS
EBITDA,2022-03-31 00:00:00,4489100000.0,TIRUMALCHM.NS
EBIT,2022-03-31 00:00:00,3922800000.0,TIRUMALCHM.NS
Net Interest Income,2022-03-31 00:00:00,-153100000.0,TIRUMALCHM.NS
Interest Expense,2022-03-31 00:00:00,169100000.0,TIRUMALCHM.NS
Interest Income,2022-03-31 00:00:00,50600000.0,TIRUMALCHM.NS
Normalized Income,2022-03-31 00:00:00,2812449520.0,TIRUMALCHM.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,2812300000.0,TIRUMALCHM.NS
Total Expenses,2022-03-31 00:00:00,16010200000.0,TIRUMALCHM.NS
Rent Expense Supplemental,2022-03-31 00:00:00,24000000.0,TIRUMALCHM.NS
Diluted Average Shares,2022-03-31 00:00:00,102388120.0,TIRUMALCHM.NS
Basic Average Shares,2022-03-31 00:00:00,102388120.0,TIRUMALCHM.NS
Diluted EPS,2022-03-31 00:00:00,27.46,TIRUMALCHM.NS
Basic EPS,2022-03-31 00:00:00,27.46,TIRUMALCHM.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,2812300000.0,TIRUMALCHM.NS
Net Income Common Stockholders,2022-03-31 00:00:00,2812300000.0,TIRUMALCHM.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,TIRUMALCHM.NS
Net Income,2022-03-31 00:00:00,2812300000.0,TIRUMALCHM.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,2812300000.0,TIRUMALCHM.NS
Net Income Continuous Operations,2022-03-31 00:00:00,2812300000.0,TIRUMALCHM.NS
Tax Provision,2022-03-31 00:00:00,941400000.0,TIRUMALCHM.NS
Pretax Income,2022-03-31 00:00:00,3753700000.0,TIRUMALCHM.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,11200000.0,TIRUMALCHM.NS
Special Income Charges,2022-03-31 00:00:00,1000000.0,TIRUMALCHM.NS
Other Special Charges,2022-03-31 00:00:00,-1000000.0,TIRUMALCHM.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-153100000.0,TIRUMALCHM.NS
Total Other Finance Cost,2022-03-31 00:00:00,34600000.0,TIRUMALCHM.NS
Interest Expense Non Operating,2022-03-31 00:00:00,169100000.0,TIRUMALCHM.NS
Interest Income Non Operating,2022-03-31 00:00:00,50600000.0,TIRUMALCHM.NS
Operating Income,2022-03-31 00:00:00,3873500000.0,TIRUMALCHM.NS
Operating Expense,2022-03-31 00:00:00,3863800000.0,TIRUMALCHM.NS
Other Operating Expenses,2022-03-31 00:00:00,1108200000.0,TIRUMALCHM.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,566300000.0,TIRUMALCHM.NS
Amortization,2022-03-31 00:00:00,1200000.0,TIRUMALCHM.NS
Depreciation Income Statement,2022-03-31 00:00:00,565100000.0,TIRUMALCHM.NS
Research And Development,2022-03-31 00:00:00,26400000.0,TIRUMALCHM.NS
Selling General And Administration,2022-03-31 00:00:00,1462900000.0,TIRUMALCHM.NS
Selling And Marketing Expense,2022-03-31 00:00:00,1350600000.0,TIRUMALCHM.NS
General And Administrative Expense,2022-03-31 00:00:00,112300000.0,TIRUMALCHM.NS
Rent And Landing Fees,2022-03-31 00:00:00,24000000.0,TIRUMALCHM.NS
Gross Profit,2022-03-31 00:00:00,7737300000.0,TIRUMALCHM.NS
Cost Of Revenue,2022-03-31 00:00:00,12146400000.0,TIRUMALCHM.NS
Total Revenue,2022-03-31 00:00:00,19883700000.0,TIRUMALCHM.NS
Operating Revenue,2022-03-31 00:00:00,19883700000.0,TIRUMALCHM.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,TIRUMALCHM.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,TIRUMALCHM.NS
Normalized EBITDA,2021-03-31 00:00:00,,TIRUMALCHM.NS
Total Unusual Items,2021-03-31 00:00:00,9700000.0,TIRUMALCHM.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,9700000.0,TIRUMALCHM.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,TIRUMALCHM.NS
Reconciled Depreciation,2021-03-31 00:00:00,,TIRUMALCHM.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,TIRUMALCHM.NS
EBITDA,2021-03-31 00:00:00,,TIRUMALCHM.NS
EBIT,2021-03-31 00:00:00,,TIRUMALCHM.NS
Net Interest Income,2021-03-31 00:00:00,,TIRUMALCHM.NS
Interest Expense,2021-03-31 00:00:00,,TIRUMALCHM.NS
Interest Income,2021-03-31 00:00:00,45900000.0,TIRUMALCHM.NS
Normalized Income,2021-03-31 00:00:00,,TIRUMALCHM.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,TIRUMALCHM.NS
Total Expenses,2021-03-31 00:00:00,,TIRUMALCHM.NS
Rent Expense Supplemental,2021-03-31 00:00:00,20100000.0,TIRUMALCHM.NS
Diluted Average Shares,2021-03-31 00:00:00,,TIRUMALCHM.NS
Basic Average Shares,2021-03-31 00:00:00,,TIRUMALCHM.NS
Diluted EPS,2021-03-31 00:00:00,,TIRUMALCHM.NS
Basic EPS,2021-03-31 00:00:00,,TIRUMALCHM.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,TIRUMALCHM.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,TIRUMALCHM.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,TIRUMALCHM.NS
Net Income,2021-03-31 00:00:00,,TIRUMALCHM.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,TIRUMALCHM.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,TIRUMALCHM.NS
Tax Provision,2021-03-31 00:00:00,,TIRUMALCHM.NS
Pretax Income,2021-03-31 00:00:00,,TIRUMALCHM.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,TIRUMALCHM.NS
Special Income Charges,2021-03-31 00:00:00,9300000.0,TIRUMALCHM.NS
Other Special Charges,2021-03-31 00:00:00,-9300000.0,TIRUMALCHM.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,TIRUMALCHM.NS
Total Other Finance Cost,2021-03-31 00:00:00,31100000.0,TIRUMALCHM.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,TIRUMALCHM.NS
Interest Income Non Operating,2021-03-31 00:00:00,45900000.0,TIRUMALCHM.NS
Operating Income,2021-03-31 00:00:00,,TIRUMALCHM.NS
Operating Expense,2021-03-31 00:00:00,,TIRUMALCHM.NS
Other Operating Expenses,2021-03-31 00:00:00,,TIRUMALCHM.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,TIRUMALCHM.NS
Amortization,2021-03-31 00:00:00,2300000.0,TIRUMALCHM.NS
Depreciation Income Statement,2021-03-31 00:00:00,,TIRUMALCHM.NS
Research And Development,2021-03-31 00:00:00,29000000.0,TIRUMALCHM.NS
Selling General And Administration,2021-03-31 00:00:00,778200000.0,TIRUMALCHM.NS
Selling And Marketing Expense,2021-03-31 00:00:00,683200000.0,TIRUMALCHM.NS
General And Administrative Expense,2021-03-31 00:00:00,95000000.0,TIRUMALCHM.NS
Rent And Landing Fees,2021-03-31 00:00:00,20100000.0,TIRUMALCHM.NS
Gross Profit,2021-03-31 00:00:00,,TIRUMALCHM.NS
Cost Of Revenue,2021-03-31 00:00:00,,TIRUMALCHM.NS
Total Revenue,2021-03-31 00:00:00,,TIRUMALCHM.NS
Operating Revenue,2021-03-31 00:00:00,,TIRUMALCHM.NS
